npj Breast Cancer (Apr 2023)
Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
- Francesco Schettini,
- Nuria Chic,
- Fara Brasó-Maristany,
- Laia Paré,
- Tomás Pascual,
- Benedetta Conte,
- Olga Martínez-Sáez,
- Barbara Adamo,
- Maria Vidal,
- Esther Barnadas,
- Aranzazu Fernández-Martinez,
- Blanca González-Farre,
- Esther Sanfeliu,
- Juan Miguel Cejalvo,
- Giuseppe Perrone,
- Giovanna Sabarese,
- Francesca Zalfa,
- Vicente Peg,
- Roberta Fasani,
- Patricia Villagrasa,
- Joaquín Gavilá,
- Carlos H. Barrios,
- Ana Lluch,
- Miguel Martín,
- Mariavittoria Locci,
- Sabino De Placido,
- Aleix Prat
Affiliations
- Francesco Schettini
- Department of Clinical Medicine and Surgery, University of Naples Federico II
- Nuria Chic
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Fara Brasó-Maristany
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Laia Paré
- SOLTI Breast Cancer Research Group
- Tomás Pascual
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Benedetta Conte
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Olga Martínez-Sáez
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Barbara Adamo
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Maria Vidal
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Esther Barnadas
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Aranzazu Fernández-Martinez
- Department of Genetics, University of North Carolina
- Blanca González-Farre
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Esther Sanfeliu
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- Juan Miguel Cejalvo
- INCLIVA Biomedical Research Institute, Hospital Clínico Universitario Valencia, University of Valencia
- Giuseppe Perrone
- Pathology Department, Campus Bio-Medico University
- Giovanna Sabarese
- Pathology Department, Campus Bio-Medico University
- Francesca Zalfa
- Pathology Department, Campus Bio-Medico University
- Vicente Peg
- Vall d´Hebron University Hospital
- Roberta Fasani
- Vall d’Hebron Institute of Oncology (VHIO)
- Patricia Villagrasa
- SOLTI Breast Cancer Research Group
- Joaquín Gavilá
- SOLTI Breast Cancer Research Group
- Carlos H. Barrios
- Centro de Pesquisa Clínica Hospital São Lucas da PUCRS
- Ana Lluch
- GEICAM, Grupo Español de Investigación en Cáncer de Mama
- Miguel Martín
- GEICAM, Grupo Español de Investigación en Cáncer de Mama
- Mariavittoria Locci
- Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II
- Sabino De Placido
- Department of Clinical Medicine and Surgery, University of Naples Federico II
- Aleix Prat
- Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute
- DOI
- https://doi.org/10.1038/s41523-023-00538-x
- Journal volume & issue
-
Vol. 9,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
